Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types.

Aapro, Matti S; Schmoll, Hans J; Jahn, Franziska; Carides, Alexandra D; Webb, R Timothy

Aapro, Matti S; Schmoll, Hans J; Jahn, Franziska; Carides, Alexandra D; Webb, R Timothy.

Affiliation

Aapro MS; IMO Clinique de Genolier, Genolier, Switzerland. maapro@genolier.net

Cancer Treat Rev ; 39(1): 113-7, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23062719

Subject(s)

Antiemetics/therapeutic use; Antineoplastic Agents/adverse effects; Morpholines/therapeutic use; Nausea/prevention & control; Vomiting/prevention & control; Antineoplastic Agents/therapeutic use; Aprepitant; Clinical Trials, Phase III as Topic; Humans; Nausea/chemically induced; Neoplasms/drug therapy; Randomized Controlled Trials as Topic; Vomiting/chemically induced

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Morpholines / Antiemetics / Nausea / Antineoplastic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Treat Rev Year: 2013 Document type: Article Affiliation country: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google